Current indications for the surgical treatment of prolactinomas
- 1 November 2015
- journal article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 22 (11) , 1785-1791
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patientsEuropean Journal of Endocrinology, 2012
- Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysisPituitary, 2011
- The prolactinomaBest Practice & Research Clinical Endocrinology & Metabolism, 2009
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Surgical Outcomes in Hyporesponsive Prolactinomas: Analysis of patients with Resistance or Intolerance to Dopamine AgonistsPituitary, 2005
- Dopamine receptor agonists for treating prolactinomasExpert Opinion on Investigational Drugs, 2002
- Late Development of Resistance to Bromocriptine in a Patient with MacroprolactinomaHormone Research in Paediatrics, 1998
- Prolactinomas Resistant to Standard Dopamine Agonists Respond to Chronic Cabergoline TreatmentThe Journal of Clinical Endocrinology & Metabolism, 1997
- A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic AmenorrheaNew England Journal of Medicine, 1994
- Bromocriptine as Primary Therapy for Prolactin-Secreting Macroadenomas: Results of a Prospective Multicenter Study*The Journal of Clinical Endocrinology & Metabolism, 1985